Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share

v3.24.1
Net Loss Per Share
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Net Loss Per Share

Note 10 Net Loss Per Share

Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Equity-classified warrants that are exercisable for nominal consideration are included in basic weighted-average shares outstanding at the time of issuance.

Diluted net loss per share gives effect to all securities having a dilutive effect on net loss, weighted-average shares of common stock outstanding, or both. The effect from potential dilutive securities included, but was not limited to: (i) incremental shares of common stock calculated using the if-converted method for the Convertible Notes due 2027 and Conversion Option Derivative, the PIPE Investment Obligation, and the Series A Preferred Stock; (ii) incremental shares of common stock calculated using the treasury stock method for warrants and share-based compensation awards; (iii) incremental shares and potential shares of common stock that were contingently issuable upon closing of the Tailwind Two Merger; and (iv) the corresponding impact to net loss associated with the preceding considerations.

The RDO Warrants and CMPO Warrants each meet the definition of a participating security because they are entitled to participate in distributions by the Company while in the form of a warrant; however, the RDO Warrants and CMPO Warrants are not required to share in the net losses of the Company. Accordingly, these participating securities do not have an impact on basic net loss per share in periods of net loss and with no distributions.

For purposes of the diluted net loss per share computation, all potentially dilutive securities, except as otherwise noted, were excluded because their (i) effect would be anti-dilutive, (ii) exercise price was “out-of-the-money,” or (iii) contingent issuance conditions were unsatisfied. However, the application of the if-converted method related to the Convertible Notes due 2027 and Conversion Option Derivative resulted in a dilutive impact to net loss per share as a result of the gain on change in fair value of the Conversion Option Derivative during 2022. Accordingly, the computation of diluted net loss per share includes the dilutive impact associated with the Convertible Notes due 2027 and the Conversion Option Derivative for 2022.

The table below represents the anti-dilutive securities that could potentially be dilutive in the future for the periods presented:

 

 

 

As of December 31,

 

(in shares of common stock)

 

2023

 

 

2022

 

Stock options

 

 

1,005,949

 

 

 

1,673,042

 

Restricted stock units

 

 

21,042,928

 

 

 

20,117,746

 

FP Combination Warrants

 

 

8,291,704

 

 

 

8,291,704

 

Combination Warrants

 

 

2,763,902

 

 

 

2,763,902

 

Public Warrants

 

 

19,221,960

 

 

 

19,221,960

 

Private Placement Warrants

 

 

78,000

 

 

 

78,000

 

2027 Warrants

 

 

17,253,279

 

 

 

17,253,279

 

RDO Warrants

 

 

29,000,000

 

 

 

 

Placement Agent Warrants

 

 

2,030,000

 

 

 

 

CMPO Warrants

 

 

23,214,290

 

 

 

 

CMPO Placement Agent Warrants

 

 

1,625,000

 

 

 

 

PIPE Investment Obligation

 

 

9,868,421

 

 

 

14,240,506

 

Conversion Option Derivative

 

 

38,733,878

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The computations of basic and diluted net loss per share for the periods presented were as follows:

 

 

 

Years Ended December 31,

 

(in thousands, except per share and share amounts)

 

2023

 

 

2022

 

Net loss - basic

 

$

(151,843

)

 

$

(163,980

)

Effect of dilutive potential shares

 

 

-

 

 

 

(23,771

)

Net loss - diluted

 

$

(151,843

)

 

$

(187,751

)

 

 

 

 

 

 

 

Weighted-average shares outstanding - basic

 

 

170,076,500

 

 

 

128,261,443

 

Dilutive potential shares

 

 

-

 

 

 

5,861,388

 

Weighted-average shares outstanding - diluted

 

 

170,076,500

 

 

 

134,122,831

 

 

 

 

 

 

 

 

Net loss per share - basic

 

$

(0.89

)

 

$

(1.28

)

Net loss per share - diluted

 

$

(0.89

)

 

$

(1.40

)